Statement by National Association of People with HIV/AIDS Regarding the 30th Anniversary of HIV/AIDS
June 02, 2011 08:00 ET
|
National Association of People with AIDS
SILVER SPRING, MD--(Marketwire - Jun 2, 2011) - NOTE TO JOURNALISTS:
For poignant stories about the impact of the 30thAnniversary of HIV/AIDS, leadership from the largest and oldest advocacy...
Immunitor Presents Positive TB Treatment Data at African Conference
February 28, 2011 06:22 ET
|
Immune Network Ltd
VANCOUVER, B.C., Feb. 28, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in...
Further Analysis of Vacc-4x Phase IIb Study Shows a Statistically Significant Reduction in Viral Load Over Placebo -- Previous Decision to Put Vacc-4x on Hold Has Been Reversed
November 18, 2010 09:05 ET
|
Bionor Pharma
OSLO, NORWAY--(Marketwire - November 18, 2010) - After further analyses of the international, randomized, double-blind, placebo-controlled multi-center phase IIb study of Bionor Pharma's (OSLO:...
Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week
November 01, 2010 09:42 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 1, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), a company in the business of discovery and development of immune-based therapies, today announced...
SafeShot Technologies Files Patents on New Low-Dose Version of Its Revolutionary Safety Injection Technology Called "Epiphany Ultra"
September 14, 2010 09:45 ET
|
SafeShot Technologies
MISSION VIEJO, CA--(Marketwire - September 14, 2010) - SafeShot Technologies, LLC, a leader in safety syringe innovation, today announced the successful development and patent filings on a new...
Henrik Lund MD Ph.D, Former Global VP in Clinical Development at Astra Zeneca, Named New CEO of Bionor Pharma ASA
August 30, 2010 09:14 ET
|
BionorPharma
OSLO, NORWAY--(Marketwire - August 30, 2010) - Bionor Pharma (OSLO: BIONOR) today announced that Henrik Lund MD Ph.D, will take over the position of CEO from Trond Syvertsen effective from 1...
Two Thirds of Study Volunteers Respond to First-Ever "Re-Vaccination" of Vacc-4x, Bionor Pharma's Peptide-Based Therapeutic HIV-Vaccine
August 30, 2010 09:13 ET
|
BionorPharma
OSLO, NORWAY and WASHINGTON, DC--(Marketwire - August 30, 2010) -
Study Highlights: 25 volunteers from previously conducted Phase 2a trial were "re-vaccinated" with the vaccine after 7...
MediaPlatform Donates Enterprise Video Platform to AIDS Documentary
August 24, 2010 11:58 ET
|
MediaPlatform, Inc.
LOS ANGELES, CA--(Marketwire - August 24, 2010) - Creating and distributing a feature-length documentary just got easier. The directors of "Building for Life," a documentary about people living...
The Ensemble Highlights 'A Spectacular Evening of Energy, Honor, and Celebration'
August 02, 2010 09:15 ET
|
The Ensemble Theatre
HOUSTON, Aug. 2, 2010 (GLOBE NEWSWIRE) -- The Ensemble Theatre kicks off its 2010 Black Tie Gala weekend filled with energy, honor, and celebration of 34 years of service to the Greater Houston...
"Next Generation" HIV/AIDS Treatments Featured in NAPWA and The AIDS Institute's Community Forum at XVIII International AIDS Conference
July 22, 2010 11:07 ET
|
National Association of People with AIDS
VIENNA, AUSTRIA--(Marketwire - July 22, 2010) - New data presented by researchers at the XVIII International AIDS Conference this week shows significant momentum for the emerging field of...